STVN
Stevanato Group SpA
NYSE: STVN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$18.28
+0.27% today
Updated 2026-05-11
Market cap
$4.99B
P/E ratio
30.47
P/S ratio
4.15x
EPS (TTM)
$0.60
Dividend yield
—
52W range
$13 – $28
Volume
0.6M
Stevanato Group SpA (STVN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $536.54M | $662.04M | $843.92M | $983.68M | $1.09B | $1.10B | $1.14B |
| Revenue growth (YoY) | — | +23.4% | +27.5% | +16.6% | +10.3% | +1.7% | +3.2% |
| Cost of revenue | $398.52M | $467.86M | $578.51M | $663.88M | $745.46M | $801.72M | $809.15M |
| Gross profit | $138.02M | $194.18M | $265.40M | $319.80M | $339.89M | $302.32M | $330.33M |
| Gross margin | 25.7% | 29.3% | 31.4% | 32.5% | 31.3% | 27.4% | 29.0% |
| R&D | $7.83M | $17.39M | $29.62M | $34.39M | $35.67M | $31.67M | $24.40M |
| SG&A | $50.57M | $58.86M | $62.50M | $85.75M | $88.95M | $93.75M | $119.06M |
| Operating income | $62.22M | $103.11M | $162.22M | $192.43M | $200.72M | $161.14M | $183.08M |
| Operating margin | 11.6% | 15.6% | 19.2% | 19.6% | 18.5% | 14.6% | 16.1% |
| EBITDA | $106.54M | $156.38M | $226.93M | $256.40M | $272.35M | $247.80M | $268.18M |
| EBITDA margin | 19.9% | 23.6% | 26.9% | 26.1% | 25.1% | 22.4% | 23.5% |
| EBIT | $60.32M | $102.27M | $170.54M | $191.58M | $193.87M | $167.15M | $183.08M |
| Interest expense | $5.30M | $6.79M | $4.87M | $3.94M | $4.32M | $6.86M | $21.80M |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $39.20M | $78.51M | $134.32M | $142.85M | $145.63M | $117.78M | $134.28M |
| Net income growth (YoY) | — | +100.3% | +71.1% | +6.3% | +1.9% | -19.1% | +14.0% |
| Profit margin | 7.3% | 11.9% | 15.9% | 14.5% | 13.4% | 10.7% | 11.8% |